login
Password reminder
Cardiac Rhythm News
Contact the editor Visit Cardiac Rhythm News Twitter feed Visit Cardiac Rhythm News Facebook page
 

Stereotaxis initiates shipments of the Epoch electrophysiology platform


Friday, 16 Dec 2011 10:32

Stereotaxis has started shipments of the Epoch platform, its comprehensive solution for the electrophysiology (EP) lab that is designed to increase efficiency in procedures with a fully-remote, networked robotic and magnetic navigation system. 


Initial shipments include system upgrades to the new generation Epoch platform from the Niobe II navigation system for customers in the USA and Europe. The company also announced the installation of the Vdrive Duo mechanical arm robotic navigation system, as part of the Epoch upgrades in Europe. The Vdrive Duo arm allows physicians to remotely manipulate a growing array of devices, such as the loop diagnostic catheter and sheath, while also manipulating the magnetic catheter.


The Epoch platform is designed to improve efficiency and enhance workflow by allowing the physician to control all aspects of the procedure remotely. It combines the proven value of remote magnetic catheter control and the efficiency benefits of remote robotic device manipulation with the Vdrive mechanical arm.


“The Epoch platform has generated tremendous market excitement since its introduction at the annual Heart Rhythm Society meeting in May,” said Michael P Kaminski, president and CEO of Stereotaxis. “As expected, the initial wave of commitments is coming from current customers who see the clear benefit to upgrade their system to Epoch. Additionally, we have experienced a surge in new prospective customers visiting our headquarters to understand how Epoch would fit their EP lab needs. We are excited about the interest in Epoch from current users and the demand curve for prospective customers, and believe we are poised for strong performance in 2012.”




Add New Comment

Related Items


Most popular


First-in-human study backs neuromodulation to treat paroxysmal atrial fibrillation
Wednesday, 06 May 2015
A first-in-human study shows low level transcutaneous electrical vagus nerve stimulation, a completely non-invasive approach, suppresses paroxysmal atrial fibrillation. First-in-human study backs neuromodulation to treat paroxysmal atrial fibrillation

Benefit of anticoagulation in AF patients with a low risk of stroke questioned
Thursday, 18 Jun 2015
The results from a retrospective study, based on a large dataset (over 140,000 patients), have cast doubt on the benefit of routine oral anticoagulants for patients with atrial fibrillation and low ... Benefit of anticoagulation in AF patients with a low risk of stroke questioned

Wednesday, 13 May 2015
The agreement will bring real-time, patient-specific heart electrical activity data to cardiac electrophysiology labs around the world to speed up the diagnosis of the sources of atrial fibrillation ... Abbott and GE Healthcare announce agreement to improve atrial fibrillation treatment

Features


Advanced technologies to improve efficacy and safety of AF ablation
Thursday, 18 Jun 2015
David Keane (Dublin, Ireland) reviews electrical indices, ultrasound, light, infrared, ultraviolet light with fluorescence and microwave technologies to improve efficacy and safety of AF ablation. Advanced technologies to improve efficacy and safety of AF ablation

Targeting the left atrial appendage for AF-related stroke prevention: Why the heart team is necessary
Wednesday, 06 May 2015
Sacha Salzberg cardiovascular surgeon comments on catheter-based and surgical approaches for left atrial appendage occlusion as treatment strategies for stroke prevention in atrial fibrillation (AF) ... Targeting the left atrial appendage for AF-related stroke prevention: Why the heart team is necessary

Profiles


Cecilia Linde
Monday, 22 Jun 2015
Cecilia Linde speaks to Cardiac Rhythm News about her work on a research platform for new onset ... Cecilia Linde

Michael Gold
Wednesday, 03 Jun 2015
William Gold spoke to Cardiac Rhythm News about his involvement in various clinical trials, his ... Michael Gold

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions